|
1
|
Li VS, Ng SS, Boersema PJ, Low TY,
Karthaus WR, Gerlach JP, Mohammed S, Heck AJ, Maurice MM, Mahmoudi
T and Clevers H: Wnt signaling through inhibition of β-catenin
degradation in an intact Axin1 complex. Cell. 149:1245–1256. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schatoff EM, Leach BI and Dow LE: Wnt
Signaling and Colorectal Cancer. Curr Colorectal Cancer Rep.
13:101–110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhan T, Rindtorff N and Boutros M: Wnt
signaling in cancer. Oncogene. 36:1461–1473. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu X, Luo F, Li J, Zhong X and Liu K:
Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon
cancer cell lines via inhibition of the Wnt signaling pathway. Int
J Oncol. 48:1333–1340. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang SM, Mishina YM, Liu S, Cheung A,
Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang Y, Wiessner
S, et al: Tankyrase inhibition stabilizes axin and antagonizes Wnt
signalling. Nature. 461:614–620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu J, Pan S, Hsieh MH, Ng N, Sun F, Wang
T, Kasibhatla S, Schuller AG, Li AG, Cheng D, et al: Targeting
Wnt-driven cancer through the inhibition of Porcupine by LGK974.
Proc Natl Acad Sci USA. 110:20224–20229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan
CW, Wei S, Hao W, Kilgore J, Williams NS, et al: Small
molecule-mediated disruption of Wnt-dependent signaling in tissue
regeneration and cancer. Nat Chem Biol. 5:100–107. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Waaler J, Machon O, Tumova L, Dinh H,
Korinek V, Wilson SR, Paulsen JE, Pedersen NM, Eide TJ, Machonova
O, et al: A novel tankyrase inhibitor decreases canonical Wnt
signaling in colon carcinoma cells and reduces tumor growth in
conditional APC mutant mice. Cancer Res. 72:2822–2832. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lau T, Chan E, Callow M, Waaler J, Boggs
J, Blake RA, Magnuson S, Sambrone A, Schutten M, Firestein R, et
al: A novel tankyrase small-molecule inhibitor suppresses APC
mutation-driven colorectal tumor growth. Cancer Res. 73:3132–3144.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Morrone S, Cheng Z, Moon RT, Cong F and Xu
W: Crystal structure of a Tankyrase-Axin complex and its
implications for Axin turnover and Tankyrase substrate recruitment.
Proc Natl Acad Sci USA. 109:1500–1505. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tanaka N, Mashima T, Mizutani A, Sato A,
Aoyama A, Gong B, Yoshida H, Muramatsu Y, Nakata K, Matsuura M, et
al: APC mutations as a potential biomarker for sensitivity to
tankyrase inhibitors in colorectal cancer. Mol Cancer Ther.
16:752–762. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim YE, Jeon HJ, Kim D, Lee SY, Kim KY,
Hong J, Maeng PJ, Kim KR and Kang D: Quantitative proteomic
analysis of 2D and 3D cultured colorectal cancer cells: Profiling
of tankyrase inhibitor XAV939-induced proteome. Sci Rep.
8:132552018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Koh B, Jeon H, Kim D, Kang D and Kim KR:
Effect of fibroblast co-culture on the proliferation, viability and
drug response of colon cancer cells. Oncol Lett. 17:2409–2417.
2019.PubMed/NCBI
|
|
14
|
Lunt SY and Vander Heiden MG: Aerobic
glycolysis: meeting the metabolic requirements of cell
proliferation. Annu Rev Cell Dev Biol. 27:441–464. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kuipers EJ, Grady WM, Lieberman D,
Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ and Watanabe T:
Colorectal cancer. Nat Rev Dis Primers. 1:150652015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ooi AT and Gomperts BN: Molecular
Pathways: Targeting cellular energy metabolism in cancer via
inhibition of SLC2A1 and LDHA. Clin Cancer Res. 21:2440–2444. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Le A, Cooper CR, Gouw AM, Dinavahi R,
Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL and Dang
CV: Inhibition of lactate dehydrogenase A induces oxidative stress
and inhibits tumor progression. Proc Natl Acad Sci USA.
107:2037–2042. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boroughs LK and DeBerardinis RJ: Metabolic
pathways promoting cancer cell survival and growth. Nat Cell Biol.
17:351–359. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo W, Shen F, Xiao W, Chen J and Pan F:
Wnt inhibitor XAV939 suppresses the viability of small cell lung
cancer NCI-H446 cells and induces apoptosis. Oncol Lett.
14:6585–6591. 2017.PubMed/NCBI
|
|
21
|
Tian XH, Hou WJ, Fang Y, Fan J, Tong H,
Bai SL, Chen Q, Xu H and Li Y: XAV939, a tankyrase 1 inhibitior,
promotes cell apoptosis in neuroblastoma cell lines by inhibiting
Wnt/β-catenin signaling pathway. J Exp Clin Cancer Res. 32:1002013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pavlova NN and Thompson CB: The Emerging
Hallmarks of Cancer Metabolism. Cell Metab. 23:27–47. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dang CV, Le A and Gao P: MYC-induced
cancer cell energy metabolism and therapeutic opportunities. Clin
Cancer Res. 15:6479–6483. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Flores A, Sandoval-Gonzalez S, Takahashi
R, Krall A, Sathe L, Wei L, Radu C, Joly JH, Graham NA, Christofk
HR and Lowry WE: Increased lactate dehydrogenase activity is
dispensable in squamous carcinoma cells of origin. Nat Commun.
10:912019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He TL, Zhang YJ, Jiang H, Li XH, Zhu H and
Zheng KL: The c-Myc-LDHA axis positively regulates aerobic
glycolysis and promotes tumor progression in pancreatic cancer. Med
Oncol. 32:1872015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pelicano H, Martin DS, Xu RH and Huang P:
Glycolysis inhibition for anticancer treatment. Oncogene.
25:4633–4646. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ono M, Yin P, Navarro A, Moravek MB, Coon
V JS, Druschitz SA, Gottardi CJ and Bulun SE: Inhibition of
canonical WNT signaling attenuates human leiomyoma cell growth.
Fertil Steril. 101:1441–1449. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Esen E, Chen J, Karner CM, Okunade AL,
Patterson BW and Long F: WNT-LRP5 signaling induces Warburg effect
through mTORC2 activation during osteoblast differentiation. Cell
Metab. 17:745–755. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He TL, Zhang YJ, Jiang H, Li XH, Zhu H and
Zheng KL: The c-Myc-LDHA axis positively regulates aerobic
glycolysis and promotes tumor progression in pancreatic cancer. Med
Oncol. 32:1872015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pate KT, Stringari C, Sprowl-Tanio S, Wang
K, TeSlaa T, Hoverter NP, McQuade MM, Garner C, Digman MA, Teitell
MA, et al: Wnt signaling directs a metabolic program of glycolysis
and angiogenesis in colon cancer. EMBO J. 33:1454–1473. 2014.
View Article : Google Scholar : PubMed/NCBI
|
